DarioHealth Corp.

NasdaqCM:DRIO Stock Report

Market Cap: US$27.3m

DarioHealth Management

Management criteria checks 4/4

DarioHealth's CEO is Erez Raphael, appointed in Aug 2013, has a tenure of 11.33 years. total yearly compensation is $722.19K, comprised of 61.8% salary and 38.2% bonuses, including company stock and options. directly owns 3.71% of the company’s shares, worth $1.01M. The average tenure of the management team and the board of directors is 3.5 years and 4.8 years respectively.

Key information

Erez Raphael

Chief executive officer

US$722.2k

Total compensation

CEO salary percentage61.8%
CEO tenure11.3yrs
CEO ownership3.7%
Management average tenure3.5yrs
Board average tenure4.8yrs

Recent management updates

Recent updates

Slammed 25% DarioHealth Corp. (NASDAQ:DRIO) Screens Well Here But There Might Be A Catch

Nov 17
Slammed 25% DarioHealth Corp. (NASDAQ:DRIO) Screens Well Here But There Might Be A Catch

A Piece Of The Puzzle Missing From DarioHealth Corp.'s (NASDAQ:DRIO) 27% Share Price Climb

Oct 03
A Piece Of The Puzzle Missing From DarioHealth Corp.'s (NASDAQ:DRIO) 27% Share Price Climb

Market Cool On DarioHealth Corp.'s (NASDAQ:DRIO) Revenues Pushing Shares 30% Lower

Aug 09
Market Cool On DarioHealth Corp.'s (NASDAQ:DRIO) Revenues Pushing Shares 30% Lower

Market Cool On DarioHealth Corp.'s (NASDAQ:DRIO) Revenues

May 31
Market Cool On DarioHealth Corp.'s (NASDAQ:DRIO) Revenues

DarioHealth Corp. (NASDAQ:DRIO) Shares Could Be 23% Below Their Intrinsic Value Estimate

Feb 16
DarioHealth Corp. (NASDAQ:DRIO) Shares Could Be 23% Below Their Intrinsic Value Estimate

Time To Worry? Analysts Just Downgraded Their DarioHealth Corp. (NASDAQ:DRIO) Outlook

Nov 06
Time To Worry? Analysts Just Downgraded Their DarioHealth Corp. (NASDAQ:DRIO) Outlook

Is DarioHealth (NASDAQ:DRIO) Using Debt Sensibly?

Oct 07
Is DarioHealth (NASDAQ:DRIO) Using Debt Sensibly?

Market Cool On DarioHealth Corp.'s (NASDAQ:DRIO) Revenues Pushing Shares 28% Lower

Aug 16
Market Cool On DarioHealth Corp.'s (NASDAQ:DRIO) Revenues Pushing Shares 28% Lower

Need To Know: Analysts Just Made A Substantial Cut To Their DarioHealth Corp. (NASDAQ:DRIO) Estimates

Aug 15
Need To Know: Analysts Just Made A Substantial Cut To Their DarioHealth Corp. (NASDAQ:DRIO) Estimates

DarioHealth Corp. (NASDAQ:DRIO) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Aug 13
DarioHealth Corp. (NASDAQ:DRIO) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

DarioHealth (NASDAQ:DRIO) Is Using Debt Safely

Oct 05
DarioHealth (NASDAQ:DRIO) Is Using Debt Safely

Need To Know: The Consensus Just Cut Its DarioHealth Corp. (NASDAQ:DRIO) Estimates For 2022

Aug 24
Need To Know: The Consensus Just Cut Its DarioHealth Corp. (NASDAQ:DRIO) Estimates For 2022

DarioHealth Q2 2022 Earnings Preview

Aug 12

DarioHealth: Paying 1.6x Equity Value For Cash Flows Priced Into The Future

Jul 29

CEO Compensation Analysis

How has Erez Raphael's remuneration changed compared to DarioHealth's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$32m

Jun 30 2024n/an/a

-US$36m

Mar 31 2024n/an/a

-US$49m

Dec 31 2023US$722kUS$446k

-US$55m

Sep 30 2023n/an/a

-US$57m

Jun 30 2023n/an/a

-US$58m

Mar 31 2023n/an/a

-US$58m

Dec 31 2022US$3mUS$490k

-US$60m

Sep 30 2022n/an/a

-US$65m

Jun 30 2022n/an/a

-US$73m

Mar 31 2022n/an/a

-US$72m

Dec 31 2021US$8mUS$461k

-US$68m

Sep 30 2021n/an/a

-US$58m

Jun 30 2021n/an/a

-US$43m

Mar 31 2021n/an/a

-US$32m

Dec 31 2020US$3mUS$284k

-US$33m

Sep 30 2020n/an/a

-US$31m

Jun 30 2020n/an/a

-US$26m

Mar 31 2020n/an/a

-US$27m

Dec 31 2019US$1mUS$249k

-US$21m

Sep 30 2019n/an/a

-US$19m

Jun 30 2019n/an/a

-US$20m

Mar 31 2019n/an/a

-US$21m

Dec 31 2018US$2mUS$205k

-US$18m

Sep 30 2018n/an/a

-US$17m

Jun 30 2018n/an/a

-US$16m

Mar 31 2018n/an/a

-US$14m

Dec 31 2017US$2mUS$147k

-US$16m

Compensation vs Market: Erez's total compensation ($USD722.19K) is about average for companies of similar size in the US market ($USD654.40K).

Compensation vs Earnings: Erez's compensation has been consistent with company performance over the past year.

CEO

Erez Raphael (51 yo)

11.3yrs

Tenure

US$722,187

Compensation

Mr. Erez Raphael has been the Chief Executive Officer of DarioHealth Corp. since August 9, 2013 and has been its Director since December 2013. Mr. Raphael served as the President of DarioHealth Corp. since...

Leadership Team

NamePositionTenureCompensationOwnership
Erez Raphael
CEO & Director11.3yrsUS$722.19k3.71%
$ 1.0m
Zvi David
CFO, Treasurer & Secretary9.9yrsUS$342.58k1.78%
$ 485.6k
Dov Oppenheim
Co-Founder & Production Chiefno datano datano data
Josh Fischer
Senior Vice President of Operations & Complianceno datano datano data
Tomer Ben-Kiki
Chief Technology Officerless than a yearno datano data
Kat Parrella
Investor Relations Managerno datano datano data
Mona Dean
Chief Compliance Officerless than a yearno datano data
Claudia Levi
Content & Communications Managerno datano datano data
Limor Drezner
Chief People Officerless than a yearno datano data
Jean Muyl
Head of Commercialization North America6.7yrsno datano data
Omar Manejwala
Chief Medical Officer4.8yrsno datano data
Brian Harrigan
Senior Vice President of Employer Sales2.3yrsno datano data

3.5yrs

Average Tenure

53yo

Average Age

Experienced Management: DRIO's management team is considered experienced (3.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Erez Raphael
CEO & Director11yrsUS$722.19k3.71%
$ 1.0m
Peter Kash
Member of Advisory Boardno datano datano data
David Horwitz
Member of the Scientific Advisory Board3.9yrsno datano data
Dennis McGrath
Independent Director11.1yrsUS$70.00k0.28%
$ 77.1k
Adam Stern
Director4.8yrsUS$50.00k1.13%
$ 309.5k
Dennis Matheis
Independent Director4.4yrsUS$70.00k0.40%
$ 109.5k
Eric Milledge
Chairman of Scientific Advisory Board4.3yrsno datano data
Hila Karah
Independent Director10.1yrsUS$70.00k0.54%
$ 147.3k
Allen Kamer
Member of Advisory Board2.9yrsUS$166.16kno data
Yoav Shaked
Independent Chairman6.4yrsUS$70.00k0.69%
$ 187.0k
Abigail Hirsch
Member of Advisory Board5.2yrsno datano data
Marilyn Ritholz
Member of the Scientific Advisory Board3.9yrsno datano data

4.8yrs

Average Tenure

60yo

Average Age

Experienced Board: DRIO's board of directors are considered experienced (4.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 02:25
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

DarioHealth Corp. is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Steven HalperCantor Fitzgerald & Co.
Steven WardellChardan Capital Markets, LLC
Raghuram SelvarajuRodman & Renshaw, LLC